In this study, we sought to uncover the genetic interactions of the anti-apoptotic protein MCL1, a clinically relevant oncogene in multiple cancers and KSHV-driven PEL [15, 17–21, 24]. Here, MCL1 is linked to primary effusion lymphoma.